Dr. Richard Popiel and Dr. Atul Butte to Assist GNS as it Applies Machine Learning to Population Health Strategies
CAMBRIDGE, Mass. – Dec. 17, 2014 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, today announced the addition of Richard Popiel, MD, MBA and Atul Butte, MD, PhD to its Scientific Advisory Board.
“These experts infuse GNS with essential insight, supporting our work with health plans, providers, foundations, and biopharma,” says Colin Hill, CEO and co-founder of GNS. “Our solutions enable smarter interventions and more precise treatment protocols, improving overall population health and dramatically reducing healthcare costs.”
Dr. Popiel is executive vice president of health care services and chief medical officer at Cambia Health Solutions. Widely regarded as a leading population health expert, Dr. Popiel previously served Horizon Blue Cross Blue Shield of New Jersey as president and chief operating officer and as vice president and chief medical officer. His work has focused on personalizing care and on implementing innovative models of care that improve patient outcomes while containing costs.
Dr. Butte is chief and associate professor, division of systems medicine, departments of pediatrics and genetics, Stanford University and the Lucile Packard Children’s Hospital. The Butte Laboratory builds and applies tools that convert more than 400 trillion points of molecular, clinical, and epidemiological data – measured by researchers and clinicians over the past decade – into diagnostics, therapeutics, and new insights into disease.
Working with healthcare payers and providers, GNS has successfully used its MAX™ care management architecture and patented REFS™ inference engine to improve efficacy of interventions related to medication adherence, metabolic syndrome, pre-term birth, and others. GNS has also advanced the research priorities of numerous nonprofit organizations focused on diseases including Huntington’s disease, multiple sclerosis (MS), childhood asthma, and Alzheimer’s disease.
About GNS Healthcare
GNS Healthcare provides analytic solutions that predict the impact of individual interventions to improve population health and reduce costs. Based on the MAX™ Care Management Architecture and patented REFS™ inference engine, GNS helps health plans and providers plan, implement and measure interventions that benefit individuals and drive population-level ROI. These cloud-based solutions are being deployed to improve outcomes associated with medication non-adherence, metabolic syndrome, diabetes, pre-term birth, and specialty care medications. GNS solutions focus on reducing adverse events, slowing disease progression, and improving therapeutic effectiveness through precision selection that reduces wasteful spending and maximizes impact.
GNS Healthcare, Driving Intelligent Interventions
www.gnshealthcare.com
Media Contact
Gina Veazey
703-254-6276
gveazey@gnshealthcare.com